Cardiac monitoring for cardiologists
This article was originally published in The Gray Sheet
Executive Summary
Medtronic will market its CardioSight data access tool to cardiologists treating heart failure patients who have one of several of the firm's resynchronization therapy defibrillators or ICD models, including the InSync Sentry CRT-D with OptiVol fluid monitoring system. Medtronic notes that CardioSight can detect dangerous fluid levels in the thoracic cavity up to two weeks prior to symptom development. The monitoring device enables non-implanting physicians to download 90 days of the patient's cardiac rhythm trends to improve treatment efficiency. Medtronic's CareLink network enables implanting physicians to remotely monitor patients with an ICD or pacemaker...